NORDIC NANOVECTOR – ANNUAL AND REMUNERATION REPORTS APPROVED
Oslo, Norway, 23 March 2023 On 22 March 2023, the Board of Directors of Nordic Nanovector ASA approved the Company's financial statements for 2022. The Company's 2022 Annual Report and ESEF file are attached. The reports are also available on Nordic Nanovector ASA's website: www.nordicnanovector.com For further information, please contact: IR enquiries Ludvik Sandnes, Interim CEO & CFOCell: +47 907 43 017Email: ir@nordicnanovector.com Media Enquiries Mark Swallow/Frazer Hall (MEDiSTRAVA Consulting)Tel: +44 203 928 6900Email: nordicnanovector@medistrava.com